You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a panel at this week's Personalized Medicine World Conference, executives and researchers discussed moving genomics into the promotion of lifetime health and prevention of disease.
Researchers tracked one individual's brain imaging patterns, physical features, blood metabolomics, gene expression, and more.
Georgia Tech researchers used high-performance mass spectrometry to uncover a highly accurate 16-marker signature that identifies women with ovarian cancer.
The cell metabolism and bioenergetics technology has been folded into Agilent's Mass Spectrometry Division in the Life Sciences and Applied Markets Group.
Four bacterial genera are found at lower levels in the gut microbiomes of three-month-old infants believed to be at risk of developing asthma later in life.
Sigma-Aldrich will distribute IROA's Mass Spectrometry Metabolite Library of Standards worldwide.
In PLOS this week: leprosy origins in Colombian populations, gene expression study of fungal pathogen Cryptococcus neoformans, and more.
The firm's approach builds on a pilot study for ISB's 100K Wellness Project, and study participants are invited to become customers.
The test is being developed as a potential replacement to liver biopsies for evaluating the efficacy of Galmed's therapeutic called Aramchol.
In PLOS this week: ancient steppe bison mitochondrial genome, proteomic study of Sauvignon Blanc grapes, and more.
A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.
Undark looks into how coronavirus-related shutdowns are affecting field researchers.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.